{
  "id": 5514812,
  "title": "Morgan Stanley abre la puerta a la corrección en Repsol",
  "url": "https://urgent.news/2026/09/04/morgan-stanley-abre-la-puerta-a-la-correccion-en-repsol",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T07:25:08.000Z",
  "source": {
    "name": "Expansion ES",
    "slug": "expansion-es",
    "url": "https://www.expansion.com/mercados/2026/09/04/6a9a68abe5fdeaaf608b45a2.html"
  },
  "original_language": "es",
  "account": "Repsol's stock has been on a strong upward trend this year, with Morgan Stanley recently lowering its price target to the lowest level in a month. Unlike other firms, Morgan Stanley does not see any medium-term upside for the energy company, as its 26.50 euro valuation represents a 6.5% downside from yesterday's closing price of 28.34 euros.",
  "summary": "El valor estrella del Ibex en lo que va de año recibe hoy la valoración más baja de las emitidas por los analistas en el último mes. A diferencia de otras firmas, Morgan Stanley no ve margen a medio plazo para que la energética amplíe su rally. Leer",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 5,
    "also_reported_by": [
      {
        "outlet": "The Business Times - Companies & Markets",
        "title": "Morgan Stanley takes aim at X accounts posting its research",
        "url": "https://urgent.news/2026/09/04/morgan-stanley-takes-aim-at-x-accounts-posting-its-research",
        "published": "2026-09-04T00:29:16.000Z"
      },
      {
        "outlet": "Straits Times Business",
        "title": "Morgan Stanley takes aim at X accounts posting its research",
        "url": "https://urgent.news/2026/09/04/morgan-stanley-takes-aim-at-x-accounts-posting-its-research-5455770",
        "published": "2026-09-04T00:43:00.000Z"
      },
      {
        "outlet": "Hindu BusinessLine",
        "title": "Cipla slips after Qilu Pembrolizumab deal; Morgan Stanley flags crowded field",
        "url": "https://urgent.news/2026/09/04/cipla-slips-after-qilu-pembrolizumab-deal-morgan-stanley-flags",
        "published": "2026-09-04T05:19:49.000Z"
      },
      {
        "outlet": "Investing.com",
        "title": "Morgan Stanley upgrades Accor on 2027 RevPAR, cash-return inflection",
        "url": "https://urgent.news/2026/09/04/morgan-stanley-upgrades-accor-on-2027-revpar-cash-return-inflection",
        "published": "2026-09-04T09:13:28.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}